Renal denervation decreases effective refractory period but not inducibility of ventricular fibrillation in a healthy porcine biomodel: a case control study
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
25591755
PubMed Central
PMC4300561
DOI
10.1186/s12967-014-0367-y
PII: s12967-014-0367-y
Knihovny.cz E-zdroje
- MeSH
- arteria renalis patologie patofyziologie MeSH
- denervace * MeSH
- elektrokardiografie MeSH
- fibrilace komor diagnostické zobrazování patofyziologie MeSH
- ledviny inervace patofyziologie MeSH
- modely nemocí na zvířatech MeSH
- refrakterní doba elektrofyziologická * MeSH
- studie případů a kontrol MeSH
- Sus scrofa MeSH
- ultrasonografie MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Ventricular arrhythmias play an important role in cardiovascular mortality especially in patients with impaired cardiac and autonomic function. The aim of this experimental study was to determine, if renal denervation (RDN) could decrease the inducibility of ventricular fibrillation (VF) in a healthy porcine biomodel. METHODS: Controlled electrophysiological study was performed in 6 biomodels 40 days after RDN (RDN group) and in 6 healthy animals (control group). The inducibility of VF was tested by programmed ventricular stimulation from the apex of right ventricle (8 basal stimuli coupled with up to 4 extrastimuli) always three times in each biomodel using peripheral extracorporeal oxygenation for hemodynamic support. Further, basal heart rate (HR), PQ and QT intervals and effective refractory period of ventricles (ERP) were measured. Technical success of RDN was evaluated by histological examination. RESULTS: According to histological findings, RDN procedure was successfully performed in all biomodels. Comparing the groups, basal HR was lower in RDN group: 79 (IQR 58; 88) vs. 93 (72; 95) beats per minute (p = 0.003); PQ interval was longer in RDN group: 145 (133; 153) vs. 115 (113; 120) ms (p < 0.0001) and QTc intervals were comparable: 402 (382; 422) ms in RDN vs. 386 (356; 437) ms in control group (p = 0.1). ERP was prolonged significantly in RDN group: 159 (150; 169) vs. 140 (133; 150) ms (p = 0.001), but VF inducibility was the same (18/18 vs. 18/18 attempts). CONCLUSIONS: RDN decreased the influence of sympathetic nerve system on the heart conduction system in healthy porcine biomodel. However, the electrophysiological study was not associated with a decrease of VF inducibility after RDN.
Zobrazit více v PubMed
Lombardi F, Verrier RL, Lown B. Relationship between sympathetic neural activity and vulnerability to ventricular-fibrillation (Vf) during myocardial ischemia and reperfusion. Circulation. 1981;64:318. PubMed
Lown B, Verrier RL. Neural activity and ventricular-fibrillation. N Engl J Med. 1976;294:1165–1170. doi: 10.1056/NEJM197603182941201. PubMed DOI
Schwartz PJ. The autonomic nervous system and sudden death. Eur Heart J. 1998;19(Suppl F):F72–F80. PubMed
La Rovere MT, Bigger JT, Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478–484. doi: 10.1016/S0140-6736(97)11144-8. PubMed DOI
Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart) Circulation. 1998;98:1510–1516. doi: 10.1161/01.CIR.98.15.1510. PubMed DOI
Lamaida N, Capuano V, Dimauro G, Aucello G, Diquacquaro GS. Possible role of beta-blockers in the prevention of sudden cardiac death (Scd) in patients with coronary heart-disease (Chd) Panminerva Med. 1994;36:71–75. PubMed
Hjalmarson A. Prevention of sudden cardiac death with beta blockers. Clin Cardiol. 1999;22:V11–V15. doi: 10.1002/clc.4960221504. PubMed DOI
Olde Nordkamp LR, Driessen AH, Odero A, Blom NA, Koolbergen DR, Schwartz PJ, Wilde AA. Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes. Neth Heart J. 2014;22:160–166. doi: 10.1007/s12471-014-0523-2. PubMed DOI PMC
Hage FG, Aggarwal H, Patel K, Chen J, Jacobson AF, Heo J, Ahmed A, Iskandrian AE. The relationship of left ventricular mechanical dyssynchrony and cardiac sympathetic denervation to potential sudden cardiac death events in systolic heart failure. J Nucl Cardiol. 2014;21:78–85. doi: 10.1007/s12350-013-9807-y. PubMed DOI
Mahfoud F, Luscher TF, Andersson B, Baumgartner I, Cifkova R, Dimario C, Doevendans P, Fagard R, Fajadet J, Komajda M, Lefèvre T, Lotan C, Sievert H, Volpe M, Widimsky P, Wijns W, Williams B, Windecker S, Witkowski A, Zeller T, Böhm M, European Society of Cardiology Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J. 2013;34:2149–2157. doi: 10.1093/eurheartj/eht154. PubMed DOI
Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–1281. doi: 10.1016/S0140-6736(09)60566-3. PubMed DOI
Symplicity HTNI, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–1909. doi: 10.1016/S0140-6736(10)62039-9. PubMed DOI
Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension. 2013;61:457–464. doi: 10.1161/HYPERTENSIONAHA.111.00194. PubMed DOI
Ukena C, Mahfoud F, Spies A, Kindermann I, Linz D, Cremers B, Laufs U, Neuberger HR, Bohm M. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. Int J Cardiol. 2013;167:2846–2851. doi: 10.1016/j.ijcard.2012.07.027. PubMed DOI
Linz D, Mahfoud F, Schotten U, Ukena C, Hohl M, Neuberger HR, Wirth K, Bohm M. Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. Hypertension. 2013;61:225–231. doi: 10.1161/HYPERTENSIONAHA.111.00182. PubMed DOI
Hou Y, Hu J, Po SS, Wang H, Zhang L, Zhang F, Wang K, Zhou Q. Catheter-based renal sympathetic denervation significantly inhibits atrial fibrillation induced by electrical stimulation of the left stellate ganglion and rapid atrial pacing. PLoS One. 2013;8:e78218. doi: 10.1371/journal.pone.0078218. PubMed DOI PMC
Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, Shirokova N, Karaskov A, Mittal S, Steinberg JS. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163–1170. doi: 10.1016/j.jacc.2012.05.036. PubMed DOI
Linz D, Wirth K, Ukena C, Mahfoud F, Poss J, Linz B, Bohm M, Neuberger HR. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs. Heart Rhythm. 2013;10:1525–1530. doi: 10.1016/j.hrthm.2013.07.015. PubMed DOI
Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, Sobotka PA, Gawaz M, Bohm M. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol. 2012;101:63–67. doi: 10.1007/s00392-011-0365-5. PubMed DOI
Hoffmann BA, Steven D, Willems S, Sydow K. Renal sympathetic denervation as an adjunct to catheter ablation for the treatment of ventricular electrical storm in the setting of acute myocardial infarction. J Cardiovasc Electrophysiol. 2013;24(12):E21. doi: 10.1111/jce.12282. PubMed DOI
McGlone JJ, Swanson J. Update on the guide for the care and use of agricultural animals in research and teaching. J Dairy Sci. 2010;93:12. doi: 10.3168/jds.2009-2244. PubMed DOI
Schwartz PJ, Verrier RL, Lown B. Effect of stellectomy and vagotomy on ventricular refractoriness in dogs. Circ Res. 1977;40:536–540. doi: 10.1161/01.RES.40.6.536. PubMed DOI
Schwartz PJ, Snebold NG, Brown AM. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol. 1976;37:1034–1040. doi: 10.1016/0002-9149(76)90420-3. PubMed DOI
Ng GA, Brack KE, Patel VH, Coote JH. Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. Cardiovasc Res. 2007;73:750–760. doi: 10.1016/j.cardiores.2006.12.001. PubMed DOI
Vanoli E, Schwartz PJ. Sympathetic–parasympathetic interaction and sudden death. Basic Res Cardiol. 1990;85(Suppl 1):305–321. PubMed
Bourke T, Vaseghi M, Michowitz Y, Sankhla V, Shah M, Swapna N, Boyle NG, Mahajan A, Narasimhan C, Lokhandwala Y, Shivkumar K. Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation. 2010;121:2255–2262. doi: 10.1161/CIRCULATIONAHA.109.929703. PubMed DOI PMC
Belohlavek J, Mlcek M, Huptych M, Svoboda T, Havranek S, Ost’adal P, Bouček T, Kovárník T, Mlejnský F, Mrázek V, Bělohlávek M, Aschermann M, Linhart A, Kittnar O. Coronary versus carotid blood flow and coronary perfusion pressure in a pig model of prolonged cardiac arrest treated by different modes of venoarterial ECMO and intraaortic balloon counterpulsation. Crit Care. 2012;16:R50. doi: 10.1186/cc11254. PubMed DOI PMC
Havranek S, Belohlavek J, Mlcek M, Huptych M, Boucek T, Svoboda T, Fichtl J, Hrachovina M, Linhart A, Kittnar O. Median frequencies of prolonged ventricular fibrillation treated by V-A ECMO correspond to a return of spontaneous circulation rate. Int J Artif Organs. 2014;1:48–57. doi: 10.5301/ijao.5000291. PubMed DOI